(SAGE) Sage Therapeutic - Performance -46.1% in 12m
Compare SAGE with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-81.54%
#141 in Group
Rel. Strength
13.16%
#6910 in Universe
Total Return 12m
-46.07%
#102 in Group
Total Return 5y
-83.32%
#93 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG 0.74
83th Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: SAGE (-46.1%) vs XBI (-14.9%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
7.21% | 14% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
7.98% | 32.4% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-7.04% | -11.2% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
11.7% | 13.3% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
2.2% | 21% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
13.3% | 27.1% | -5.64% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
27.3% | -15% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20% | 0.38% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: SAGE vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for SAGE
Total Return (including Dividends) | SAGE | XBI | S&P 500 |
---|---|---|---|
1 Month | -8.38% | 2.77% | 5.69% |
3 Months | -8.76% | -14.21% | -6.49% |
12 Months | -46.07% | -14.88% | 9.72% |
5 Years | -83.32% | -26.47% | 107.51% |
Trend Score (consistency of price movement) | SAGE | XBI | S&P 500 |
1 Month | -36.3% | 57% | 89.4% |
3 Months | 0.50% | -82.3% | -72% |
12 Months | -58.4% | -53.1% | 49.3% |
5 Years | -83.4% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #150 | -10.9% | -13.3% |
3 Month | #51 | 6.35% | -2.43% |
12 Month | #102 | -36.7% | -50.9% |
5 Years | #97 | -77.3% | -92.0% |
FAQs
Does SAGE Sage Therapeutic outperforms the market?
No,
over the last 12 months SAGE made -46.07%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.88%.
Over the last 3 months SAGE made -8.76%, while XBI made -14.21%.
Over the last 3 months SAGE made -8.76%, while XBI made -14.21%.
Performance Comparison SAGE vs Indeces and Sectors
SAGE vs. Indices SAGE is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -8.66% | -14.1% | 9.28% | -55.8% |
US NASDAQ 100 | QQQ | -8.93% | -15.8% | 8.87% | -56.9% |
US Dow Jones Industrial 30 | DIA | -8.55% | -11.1% | 10.3% | -52.3% |
German DAX 40 | DAX | -9.11% | -23.4% | -16.3% | -70.9% |
Shanghai Shenzhen CSI 300 | CSI 300 | -8.89% | -11.3% | 10.1% | -52.4% |
Hongkong Hang Seng | HSI | -11.5% | -23.3% | -0.21% | -54.3% |
India NIFTY 50 | INDA | -4.96% | -11.6% | 7.38% | -48.1% |
Brasil Bovespa | EWZ | -11.7% | -20.0% | 0.07% | -39.8% |
SAGE vs. Sectors SAGE is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -8.03% | -14.9% | 3.10% | -66.5% |
Consumer Discretionary | XLY | -10.1% | -15.1% | 11.5% | -60.9% |
Consumer Staples | XLP | -7.80% | -9.08% | 2.37% | -53.3% |
Energy | XLE | -10.9% | -12.9% | 15.3% | -37.1% |
Financial | XLF | -9.36% | -15.2% | 3.40% | -67.6% |
Health Care | XLV | -4.56% | -5.32% | 14.5% | -40.1% |
Industrial | XLI | -9.59% | -16.7% | 8.30% | -56.4% |
Materials | XLB | -8.82% | -13.4% | 13.3% | -40.0% |
Real Estate | XLRE | -7.87% | -15.3% | 6.90% | -59.6% |
Technology | XLK | -9.50% | -18.1% | 11.6% | -52.2% |
Utilities | XLU | -9.38% | -13.5% | 1.51% | -62.1% |
Aerospace & Defense | XAR | -8.84% | -17.6% | -0.02% | -72.0% |
Biotech | XBI | -0.94% | -11.2% | 30.3% | -31.2% |
Homebuilder | XHB | -8.30% | -14.0% | 22.9% | -37.2% |
Retail | XRT | -8.72% | -14.5% | 15.6% | -39.8% |